ZA200606135B - Compositions comprising HIV protease inhibitor and cytochrome P450 enzyme activity inhibitor - Google Patents
Compositions comprising HIV protease inhibitor and cytochrome P450 enzyme activity inhibitorInfo
- Publication number
- ZA200606135B ZA200606135B ZA200606135A ZA200606135A ZA200606135B ZA 200606135 B ZA200606135 B ZA 200606135B ZA 200606135 A ZA200606135 A ZA 200606135A ZA 200606135 A ZA200606135 A ZA 200606135A ZA 200606135 B ZA200606135 B ZA 200606135B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibitor
- cytochrome
- compositions
- enzyme activity
- hiv protease
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54074604P | 2004-01-30 | 2004-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200606135B true ZA200606135B (en) | 2008-01-30 |
Family
ID=37722511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200606135A ZA200606135B (en) | 2004-01-30 | 2006-07-24 | Compositions comprising HIV protease inhibitor and cytochrome P450 enzyme activity inhibitor |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1913889A (en) |
ZA (1) | ZA200606135B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ591951A (en) * | 2008-10-07 | 2013-02-22 | Janssen R & D Ireland | New amide compounds as boosters of antivirals |
CN104523967B (en) * | 2014-12-12 | 2017-08-01 | 扬子江药业集团北京海燕药业有限公司 | A kind of Bai Ai capsules as CYP enzyme inhibitors application |
-
2005
- 2005-01-17 CN CN 200580003484 patent/CN1913889A/en active Pending
-
2006
- 2006-07-24 ZA ZA200606135A patent/ZA200606135B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1913889A (en) | 2007-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL281228A (en) | A variant form of urate oxidase and use thereof | |
EP2285216A4 (en) | Hiv protease inhibitor and cytochrome p450 inhibitor combinations | |
IL190521A0 (en) | Nucleic acids encoding modified cytochrome p450 enzymes and methods of use thereof | |
IL162353A0 (en) | Combination of cytochrome p450 dependent protease inhibitors | |
TWI366467B (en) | Variant forms of urate oxidase and use thereof | |
EP2620150A3 (en) | 2-amido thiazole based inhibitors of ATP-utilizing enyzmes | |
IL179056A0 (en) | An hiv protease inhibitor | |
ZA200803368B (en) | Nucleic acids encoding modified cytochrome P450 enzymes and methods of use thereof | |
TWI365876B (en) | Prodrugs of hiv protease inhibitors | |
WO2008048121A3 (en) | Macrocyclic cysteine protease inhibitors and compositions thereof | |
IL181819A0 (en) | Enzyme inhibitors and uses thereof | |
ZA200606135B (en) | Compositions comprising HIV protease inhibitor and cytochrome P450 enzyme activity inhibitor | |
IL176675A0 (en) | Compositions comprising hiv protease inhibitor and cytochrome p450 enzyme activity inhibitor | |
EP1838337A4 (en) | Cytochrome p450 enzyme complexes and methods of treatment using the same | |
AU2003247948A8 (en) | Cytochrome p450 genetic variations | |
GB0421920D0 (en) | Cytochrome P450 enzymes and cancer | |
AU2003244413A8 (en) | Cytochrome p450 protein | |
EP1579869A1 (en) | Pharmaceutical compositions containing lipase, especially pancreatin, and tensides | |
GB0319035D0 (en) | Cytochrome p450 protein |